Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹2,302Cr
Rev Gr TTM
Revenue Growth TTM
5.46%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

BHARATRAS
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -31.2 | -26.9 | -9.9 | -24.7 | 1.2 | 18.0 | 24.7 | 10.1 | -1.0 | 33.7 | -12.8 | 5.5 |
| 247 | 234 | 248 | 205 | 240 | 244 | 273 | 215 | 266 | 304 | 253 | 228 |
Operating Profit Operating ProfitCr |
| 19.2 | 2.3 | 5.5 | 12.0 | 22.4 | 13.5 | 16.7 | 16.3 | 13.1 | 19.4 | 11.6 | 15.8 |
Other Income Other IncomeCr | -6 | 9 | 2 | 2 | 22 | 22 | -1 | 18 | 3 | -12 | 11 | 17 |
Interest Expense Interest ExpenseCr | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 7 | 6 | 6 | 7 | 6 | 6 | 6 | 7 | 7 | 6 | 6 | 7 |
| 46 | 8 | 10 | 22 | 84 | 53 | 46 | 52 | 35 | 54 | 36 | 52 |
| 15 | 1 | 4 | 6 | 17 | 10 | 14 | 11 | 9 | 14 | 8 | 12 |
|
Growth YoY PAT Growth YoY% | -53.1 | -81.2 | -73.8 | -54.7 | 121.8 | 508.2 | 435.7 | 164.7 | -62.5 | -8.0 | -13.3 | -1.2 |
| 9.9 | 3.0 | 2.3 | 6.6 | 21.7 | 15.3 | 9.8 | 15.8 | 8.2 | 10.5 | 9.8 | 14.8 |
| 18.2 | 4.3 | 3.6 | 9.2 | 40.4 | 25.9 | 19.3 | 24.4 | 15.1 | 23.9 | 16.8 | 24.1 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 22.4 | -10.1 | 19.1 | -5.1 | -15.4 | 12.3 | 5.7 |
| 805 | 986 | 852 | 1,050 | 1,037 | 927 | 998 | 1,051 |
Operating Profit Operating ProfitCr |
| 18.9 | 18.9 | 21.9 | 19.3 | 16.0 | 11.2 | 14.9 | 15.3 |
Other Income Other IncomeCr | 1 | 14 | 5 | 14 | 9 | 35 | 42 | 19 |
Interest Expense Interest ExpenseCr | 16 | 16 | 4 | 7 | 6 | 3 | 5 | 5 |
Depreciation DepreciationCr | 17 | 22 | 26 | 25 | 26 | 26 | 27 | 27 |
| 155 | 205 | 215 | 234 | 174 | 123 | 185 | 176 |
| 44 | 48 | 51 | 58 | 49 | 28 | 44 | 44 |
|
| | 41.4 | 4.0 | 7.4 | -29.2 | -23.4 | 47.5 | -5.8 |
| 11.2 | 13.0 | 15.0 | 13.5 | 10.1 | 9.1 | 12.0 | 10.7 |
| 65.6 | 92.8 | 96.4 | 105.9 | 75.0 | 57.5 | 84.8 | 79.8 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| 405 | 560 | 723 | 766 | 889 | 984 | 1,126 | 1,193 |
Current Liabilities Current LiabilitiesCr | 293 | 153 | 170 | 304 | 171 | 197 | 261 | 241 |
Non Current Liabilities Non Current LiabilitiesCr | 54 | 34 | 10 | 11 | 10 | 13 | 17 | 18 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 564 | 519 | 650 | 797 | 791 | 907 | 1,093 | 1,135 |
Non Current Assets Non Current AssetsCr | 192 | 233 | 258 | 289 | 283 | 291 | 315 | 321 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -52 | 263 | 170 | -65 | 213 | 41 | 172 |
Investing Cash Flow Investing Cash FlowCr | -48 | -68 | -153 | 51 | -61 | -90 | -157 |
Financing Cash Flow Financing Cash FlowCr | 102 | -169 | -40 | -25 | -152 | 49 | -1 |
|
Free Cash Flow Free Cash FlowCr | -100 | 204 | 160 | -121 | 191 | 14 | 137 |
| -46.9 | 166.6 | 103.9 | -37.2 | 171.2 | 43.0 | 122.1 |
CFO To EBITDA CFO To EBITDA% | -28.0 | 114.6 | 71.0 | -26.1 | 108.3 | 35.0 | 98.4 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 1,777 | 2,214 | 3,998 | 5,061 | 3,778 | 3,531 | 4,378 |
Price To Earnings Price To Earnings | 15.9 | 14.0 | 24.4 | 28.8 | 30.3 | 37.0 | 31.1 |
Price To Sales Price To Sales | 1.8 | 1.8 | 3.7 | 3.9 | 3.1 | 3.4 | 3.7 |
Price To Book Price To Book | 4.3 | 3.9 | 5.5 | 6.6 | 4.2 | 3.6 | 3.9 |
| 10.8 | 9.8 | 16.8 | 20.8 | 19.1 | 30.4 | 25.2 |
Profitability Ratios Profitability Ratios |
| 31.1 | 30.9 | 37.4 | 35.2 | 32.0 | 31.0 | 33.8 |
| 18.9 | 18.9 | 21.9 | 19.3 | 16.0 | 11.2 | 14.9 |
| 11.2 | 13.0 | 15.0 | 13.5 | 10.1 | 9.1 | 12.0 |
| 26.1 | 33.6 | 27.9 | 25.5 | 19.5 | 11.8 | 15.6 |
| 27.3 | 27.9 | 22.5 | 22.9 | 13.9 | 9.7 | 12.5 |
| 14.8 | 21.0 | 18.1 | 16.2 | 11.6 | 8.0 | 10.0 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Bharat Rasayan Limited (**BRL**) is a leading Indian manufacturer of **Technical Grade Pesticides** and **Intermediates**. Established in **1989**, the company has evolved into a vertically integrated player in the agrochemical value chain. BRL specializes in the production of **Insecticides, Fungicides, and Herbicides**, serving a diverse global clientele across **28 countries** and a domestic network spanning **20 Indian states**.
---
### **Manufacturing Infrastructure and Strategic Expansion**
BRL operates a robust manufacturing footprint designed for high-volume production and stringent quality control. The company is currently in a phase of significant capital expenditure to enhance its capacity and backward integration.
* **Unit-I (Mokhra, Haryana):** The foundation of BRL’s manufacturing operations, focusing on technical grade production.
* **Unit-II (Dahej, Gujarat):** Located in the GIDC industrial hub, this facility was recently restored to **full capacity** in **February 2024** following a fire incident in 2022. It serves as a critical hub for export-oriented production.
* **Unit-III (Dahej-3, Gujarat):** Currently **under construction**, this unit is a cornerstone of BRL’s growth strategy, aimed at scaling manufacturing for next-generation formulations and technical products.
* **Operational Standards:** All units are **Zero Liquid Discharge (ZLD)** facilities. BRL adheres to global standards including **ISO 9001:2015** (Quality), **ISO 14001:2015** (Environment), **ISO 45001:2018** (Health & Safety), and **ISO 50001:2018** (Energy).
---
### **Product Portfolio and Market Specialization**
BRL’s primary competitive advantage lies in its specialization in **Soil Active Herbicides**, which represent the largest share of its business.
* **Herbicide Dominance:** The portfolio includes **Synthetic Herbicides** (growth regulators) and **Bio-herbicides** used across cereals, grains, oilseeds, pulses, fruits, and vegetables.
* **Application Versatility:** Products are developed for all agricultural stages: **Pre-plant, Pre-emergence, and Post-emergence**.
* **Growth Drivers:** The company is pivoting toward **Green Herbicides** and products compatible with **Genetically Modified (GM)** herbicide-resistant crops to meet evolving global agricultural demands.
* **Safety & Compliance:** Every consignment is supported by a **Material Safety Data Sheet (MSDS)** and emergency "term cards" to ensure safety throughout the supply chain.
---
### **Research, Development, and Innovation**
BRL maintains a self-reliant technology profile, utilizing internal R&D rather than imported technology. It operates two dedicated facilities recognized by the **Ministry of Science and Technology**:
| Facility Location | Certifications | Strategic Focus |
| :--- | :--- | :--- |
| **Bahadurgarh, Haryana** | Ministry of Science & Tech | New chemistries, process safety, and pilot plant testing. |
| **Dahej, Gujarat** | **NABL Certified** | Quality assurance, technical competitiveness, and commercial viability. |
The R&D team focuses on **backward integration**, developing processes for critical raw materials to reduce dependency on external suppliers (particularly from China) and stabilize profit margins.
---
### **Strategic Joint Venture: Nissan Bharat Rasayan Pvt. Ltd. (NBRPL)**
A pivotal element of BRL’s long-term strategy is its **30/70 Joint Venture** with **Nissan Chemical Corporation (NCC)**, Japan.
* **Objective:** Manufacturing specialized agrochemicals developed through NCC’s proprietary research for both Indian and global markets.
* **Financial Performance:** For the nine months ended **December 31, 2025**, the JV reported revenue of **₹226.45 crore** and a PAT of **₹12.53 crore**.
* **Strategic Value:** The JV allows BRL to participate in high-entry-barrier technical products and strengthens its position as a preferred partner for Japanese chemical majors.
---
### **Financial Performance and Capital Structure**
BRL has demonstrated a strong recovery in **FY 2024-25**, rebounding from industry-wide volatility.
**Key Financial Metrics:**
| Metric (₹ in Crores) | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- | :--- |
| **Revenue (Turnover)** | **1,199.02** | **1,065.53** | **1,253.68** |
| **Profit After Tax (PAT)** | **125.10** | **81.61** | **130.83** |
| **Export % of Turnover** | **26.61%** | **36.13%** | **55.12%** |
**Corporate Actions & Shareholding:**
In **December 2025**, BRL executed a **1:1 bonus issue** and a **stock split** (Face Value reduced from **₹10** to **₹5**) to improve liquidity.
* **Paid-up Capital:** Increased to **₹8.31 crore** (1,66,21,072 shares).
* **Credit Ratings:** Maintained at **CARE AA- (Stable)** for long-term and **CARE A1+** for short-term facilities.
* **Promoter Holding:** The promoter group maintains a significant stake, led by Mahabir Prasad Gupta and Rajender Prasad Gupta.
---
### **Strategic Growth Levers**
BRL is positioning itself to benefit from the **"China plus one"** strategy and India's emergence as a global sourcing hub.
* **Capacity Scaling:** The construction of **Unit-III** is expected to drive the next leg of volume growth.
* **Portfolio Diversification:** Increasing focus on high-margin segments including **seeds** and **crop nutrition**.
* **Sustainable Procurement:** Approximately **65%** of procurement is classified as sustainable, with a focus on localized sourcing to mitigate global supply chain disruptions.
---
### **Risk Factors and Mitigation**
Investors should monitor several operational and macro-economic risks:
* **Litigation & Regulatory:** Following the 2022 Dahej fire, the **National Green Tribunal (NGT)** imposed **₹11.80 crore** in environmental compensation. This is currently being contested in the **Supreme Court**.
* **Insurance Recovery:** Claims for property damage at the Dahej plant are ongoing; **Loss of Profit (FLOP)** claims are recognized only upon receipt, which may cause quarterly earnings volatility.
* **Market Dynamics:** The industry faces **oversupply from China**, leading to pricing pressure and global destocking trends in Latin America and Southeast Asia.
* **Climatic Dependency:** As an agrochemical player, BRL’s domestic revenue is highly sensitive to the **spatial distribution of the Indian monsoon**.
* **Currency Risk:** The JV (NBRPL) is susceptible to foreign exchange fluctuations, reporting a **₹13.68 crore** forex loss in FY2025.